TOL - 24th Aug, 2021
Believe in the expansion
|
The Delta variant has become the predominant strain of COVID-19 in much of the world. In response, we're seeing a return to lockdowns and other socially restrictive measures. The resulting negative impact on the global economy is apparent. However, Morgan Stanley believes this will only moderate expected growth rates, with the expansion continuing. Three key reasons the expansion will continue, despite Delta:
|
|
US Economic data is strong
Focusing on recent US economic data, which has garnered the most attention, reported GDP growth has been lower than expected. However, it is important to note the source of this miss, which is primarily due to inventory de-stocking and ongoing supply-chain issues. Inventory represents economic activity created in a previous period, so lowering inventory levels does not contribute to economic activity today. Accordingly, inventory de-stocking and supplier bottlenecks hold back economic activity. Conversely, consumption and business investment are in line with Morgan Stanley’s estimates, and these are the key drivers of private domestic growth (see US Economics: How We Are Tracking, 30 July 2021). We believe it is just a matter of time for day-to-day business activity to return to normal and the expansion to continue. Exhibit 1 – Morgan Stanley Business Conditions Index 
Source: Morgan Stanley Research. Note: +50 = Expanding. Looking at employment, Morgan Stanley's Business Conditions Index (see Exhibit 1) shows business sentiment moderating but remaining at an elevated level in July. More notable is the sub-index measures for hiring and capital expenditure. The hiring sub-index, which measures the pace of hiring, has surged over the past three months to 71 - the highest ever reading. While the Capital Expenditure Plan sub-index, which gauges business investment intentions, rose to 68 - just 3 points below this cycle's high in June 2021 (see US Economics: Business Conditions – A Record Pace of Hiring, 12 August 2021). In another sign that labour activity is increasingly contributing to the momentum in the economy, working-from-home trends seem to be reversing. Before COVID-19, Morgan Stanley's AlphaWise US Consumer Pulse survey showed that about 30% of employed adults reported spending some of the working week at home. In January 2021, this had increased to 53%. As of July 9, this had fallen back to 38%. This has supported a rebound in spending categories like public transport as well as laundry and dry cleaning and is consistent with our forecasts that consumer spending will shift back towards services and away from goods retailing (see US Economics: Back to Work, 23 July 2021). Exhibit 2 – Personal Consumption Expenditure Index 
Source: Bureau of Economic Analysis. Morgan Stanley Research. T = 4Q19 This increase in activity is leading to inflation coming in slightly stronger than Morgan Stanley had anticipated. In July, the modest upward pressure we saw in the producer price index (PPI) offset the cooling in the consumer price index (CPI). However, the net impact on our estimate for July's core personal consumption expenditure (PCE) was to only increase it from 3.5% to 3.6%. Core PCE is the preferred inflation measure used by the US Federal Reserve in determining its monetary policy settings. Growth at 3.6% versus last year remains consistent with our expectation for elevated near-term inflation. Last year's recessionary conditions will distort prior-year comparisons. Morgan Stanley continues to expect Core PCE to moderate in 2022 but remain above the US Fed's 2% inflation target (see US Economics: PPI, 12 August 2021). Exhibit 3 – Core PCE Inflation 
Source: Morgan Stanley Research estimates The Build Back Better legislation is comingThe US Senate has passed a bipartisan US$1 trillion infrastructure package, which was around US$550 billion above baseline spending. While a political victory for President Biden, who has sought to govern with bipartisan support, the path through the House of Representatives remains uncertain. President Biden’s Build Back Better legislation is comprised of two sections. The second component, which is focused more on social policies like free community college, healthcare subsidies, and childcare tax credits, amounts to around US$3.5 trillion and is being used by House Democrats as a condition for their support of the initial US$1 trillion infrastructure package. Further complicating the process will be the negotiations as to how the spending will be funded. However, Morgan Stanley’s base case remains that a bipartisan path remains open for the entire Build Back Better legislation to be passed. This would provide a material, deficit-funded spending boost to the US and global economy (see Public Policy Brief: Infrastructure Week...What You Need to Know, 3 August 2021). The US can carry its deficit and debtsAs noted by Morgan Stanley’s global macroeconomics team (Global and US Economics: Debt Sustainability: r-g Is Key, 14 July 2021), managing the aftermath of debt build-ups is key to understanding long term consequences for the US economy as well as other economies more broadly. Morgan Stanley reviewed 76 instances over the past 100 years where economies experienced a comparable build-up in public debt and found the best outcome occurred when real GDP growth was greater than real interest rates. We also found that the best results were tied to extended periods of looser monetary and fiscal policies - leading to faster economic growth and a quicker return to full employment. Once the economy was on a self-sustaining path, policymakers could adjust policies back towards tighter conditions. Inflation is the main risk for policymakers, but it appears this is well understood and contained for now. However, the risk to our expansionary scenario comes from two sources: the Delta strain and China/US tensions.
The current COVID vaccines remain effective against severe disease, hospitalisation and death. However, additional variants might emerge that prove resistant to these currently available vaccines, in turn forcing more severe lockdowns and impacting economic activity. It is important to note Morgan Stanley believes the rising case count obscures the reality that vaccinations are working to control the virus. Our US work points to significantly higher infections if the rollout of vaccines had not occurred. (see Biotechnology: COVID-19: Putting Delta in Perspective, 27 July 2021). Exhibit 4 – Adjusted Covid-19 case numbers assuming no vaccines – Florida example 
Source: Morgan Stanley Research. Data.cdc.gov. Morgan Stanley recently hosted a panel discussion with US/China relationship experts. They identified potential catalysts that might bring trade tensions between the US and China back into focus (see Podcast | Thoughts on the Market: Michael Zezas: The Return of US-China Trade Tensions?, 11 August 2021). These included:
The bottom line
While we acknowledge the impact on economic activity from the rise of the COVID-19 Delta variant, underlying activity remains robust, while the desire for a return to "normal" remains as strong as ever. In addition, the US Build Back Better legislation remains on track. This legislation, in particular, should provide a significant economic boost. We continue to expect equity markets to take a gradual path to generally higher levels in 12 months. We continue to favour the Quality factor and, to a lesser extent, the Value factor and prefer International over Australian equities. Fixed-income allocations remain tilted towards credit for improved yield at the expense of duration. Cash currently remains our least favoured asset class. Learn morePlease click 'Contact' if you would like a copy of the full report. |
|
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Nathan Lim is the Chief Investment Officer at Lonsec Holdings. He is responsible for building and managing Lonsec’s suite of investment solutions, devising strategies for growth and acting as the liaison with the market. Nathan has industry-recognised expertise, having won multiple awards for portfolio management and fund selection in both conventional and Responsible Investment categories.
........
The information and opinions in Morgan Stanley Wealth Management Research were prepared by Morgan Stanley Wealth Management Australia Pty Ltd (ABN 19 009 145 555, holder of Australian Financial Services License No. 240813) ("Morgan Stanley Wealth Management"), and Morgan Stanley Wealth Management takes responsibility for the production of this report. Morgan Stanley Wealth Management’s Research Department produces and distributes research products for clients of Morgan Stanley Wealth Management.
This Morgan Stanley Wealth Management Research is disseminated and available only in Australia.
For important disclosures (including copies of historical disclosures) regarding the securities and/or companies that are the subject of this Morgan Stanley Wealth Management Research product, please contact Morgan Stanley Wealth Management Research, Level 26 Chifley Tower, 2 Chifley Square, Sydney NSW 2000, Attention: Research Management. In addition, the same important disclosures, with the exception of the historical disclosures, are contained on the Firm's disclosure website: https://www.morganstanley.com/online/researchdisclosures Historical disclosures will be provided upon request back to June 1, 2009.
In addition, please contact us if you require Morgan Stanley Wealth Management Research model portfolio performance figures for previous periods.
Global Research Conflict Management Policy
Morgan Stanley Wealth Management has a Conflict Management policy available at:
https://www.morganstanley.com/online/researchconflictpolicies
Morgan Stanley & Co. LLC Stock Rating System & Definitions
For an explanation of Morgan Stanley's Stock Rating system and definitions, please refer to Morgan Stanley Wealth Management’s disclosure
website: https://www.morganstanley.com/online/researchdisclosures
Hybrid and Convertible Securities Rating System and Definitions
The value of hybrid and convertible securities can be impacted by a number of events including but not limited to movements in credit spreads, secondary market liquidity, and relative attractiveness of hybrid returns versus other asset classes. Significant event risk can also impact the value of hybrid and convertible securities. These include, but are not limited to credit adjustment by rating agencies, underlying entity fundamentals, changes in the tax and or regulatory environment, solvency issues surrounding the underlying entity and changes to the duration or maturity date. For a large number of investment grade securities, the rights to redeem, convert, change, and/or extend the terms lie with the issuer and not the holder of the security. Morgan Stanley Wealth Management cannot make an assessment on potential changes to terms until they have been announced by the issuer. Neither the capital value nor the distribution income of hybrid or convertible securities is guaranteed. In an event of default, hybrid securities may rank ahead of equity holders but behind debt holders in the winding up of an entity. For full terms & conditions of each hybrid or convertible security, including specific risks related to each security, refer to the prospectus or product disclosure statement available from your Financial Adviser. Morgan Stanley Wealth Management Research does not necessarily cover the underlying equity securities for hybrid and convertible securities mentioned in this report.
Investment Risk Rating: Morgan Stanley Wealth Management’s hybrids and convertibles risk ratings assess the risk of each security based on a number of quantitative and qualitative factors, including the financial strength of the issuer, debt/equity ratio of the issuer, interest cover of the issuer, the issuer’s ability to pay distributions, conversion risk, dilution risk of conversion into equity, and duration risk. Risk ratings assess both the risk of the issuer and the specific risk of the actual security. An issue can be rated high risk for example, despite the issuer being of sound financial health, due to security specific terms which are security holder ‘unfriendly’, or there is a high degree of uncertainty (and therefore “redemption value”) on the exit and/or conversion conditions.
Each security will then be given one of four ratings:
Low Risk – a security is backed by an entity that has strong capacity to meet its financial obligations and commitments. The risk of the entity missing a distribution payment is considered low.
Medium Risk – a security is backed by an entity that exhibits adequate protection parameters, however, adverse economic conditions or changes in circumstances could lead to a weakened capacity of the entity to meet its financial obligations.
High Risk – a security is backed by an entity that is more vulnerable to adverse economic conditions which may lead to distributions being lowered or cancelled. A security may also be considered High Risk when the outcomes surrounding the maturity date are largely unknown.
Speculative Risk – a security is backed by an entity that is highly vulnerable to adverse economic conditions. An entity may also be showing signs of financial stress. There is a high degree of uncertainty surrounding the entity’s ability to make a regular distribution payment.
The research analysts or strategists principally responsible for the preparation of Morgan Stanley Wealth Management Research have received compensation based upon various factors, including quality of research, investor client feedback, competitive factors, and firm profitability or revenues (which include fixed income trading and capital markets profitability or revenues). Research analysts' or strategists' compensation is not linked to the profitability or revenues of particular capital markets transactions performed by Morgan Stanley Wealth Management or the profitability or revenues of particular fixed income trading desks. Morgan Stanley Wealth Management and its affiliates do business that relates to companies/instruments covered in Morgan Stanley Wealth Management Research. Morgan Stanley Wealth Management and/or its affiliates sells to and buys from customers the securities/instruments of companies covered in Morgan Stanley Wealth Management Research on a principal basis. This communication has been prepared solely for information purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The material contained herein is not intended to constitute investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To the extent this communication is deemed to contain any general financial advice, such advice is prepared without taking account your objectives, financial situation or needs and because of this, you should, before acting on the general advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If the advice relates to the acquisition of a particular financial product for which a product disclosure statement or other disclosure document (‘offer document’) is available, you should obtain the offer document relating to the particular product and consider it before making any decision whether to acquire the product. Morgan Stanley Wealth Management recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a Financial Adviser. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. The securities, instruments, or strategies discussed in Morgan Stanley Wealth Management Research may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them.
Morgan Stanley Smith Barney LLC, its affiliates and Morgan Stanley Financial Advisers do not provide legal or tax advice. Each client should always consult his/her personal tax and/or legal adviser for information concerning his/her individual situation and to learn about any potential tax or other implications that may result from acting on a particular recommendation. Morgan Stanley Wealth Management Research is not an offer to buy or sell or the solicitation of an offer to buy or sell any security/instrument or to participate in any particular trading strategy. The important disclosures contained on the Firm's disclosure website at: https://www.morganstanley.com/online/researchdisclosures list all companies mentioned where Morgan Stanley Wealth Management or Morgan Stanley & Co. LLC owns 1% or more of a class of common equity securities of the securities/instruments of companies. Morgan Stanley Wealth Management or its affiliates may trade securities/instruments or derivatives of securities/instruments in ways different from those discussed in Morgan Stanley Wealth Management Research.
Employees of Morgan Stanley Wealth Management not involved in the preparation of Morgan Stanley Wealth Management Research may have investments in securities/instruments or derivatives of securities/instruments of companies mentioned and may trade them in ways different from those discussed in Morgan Stanley Wealth Management Research. Morgan Stanley Wealth Management Research is based on public information. Morgan Stanley Wealth Management makes every effort to use reliable, comprehensive information, but we make no representation that it is accurate or complete. We have no obligation to tell you when opinions or information in Morgan Stanley Wealth Management Research change apart from when we intend to discontinue equity research coverage of a subject company. Facts and views presented in Morgan Stanley Wealth Management Research have not been reviewed by, and may not reflect information known to, professionals in other Morgan Stanley Wealth Management business areas, including investment banking personnel.
The value of and income from your investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, securities/instruments prices, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realised. If provided, and unless otherwise stated, the closing price on the cover page is that of the primary exchange for the subject company's securities/instruments. Morgan Stanley Wealth Management and its affiliates may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report. The trademarks and service marks contained in Morgan Stanley Wealth Management Research are the property of their respective owners. Third-party data providers make no warranties or representations of any kind relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages of any kind relating to such data.
Morgan Stanley Wealth Management Research, or any portion thereof may not be reprinted, sold or redistributed without the written consent of Morgan Stanley Wealth Management.
Morgan Stanley Wealth Management Research is disseminated and available primarily electronically, and, in some cases, in printed form.
This report was prepared solely upon information generally available to the public. No representation is made that it is accurate and complete.
Additional information on recommended securities/instruments is available on request.
© 2021 Morgan Stanley Wealth Management Australia Pty Ltd
4 topics
Nathan Lim is the Chief Investment Officer at Lonsec Holdings. He is responsible for building and managing Lonsec’s suite of investment solutions, devising strategies for growth and acting as the liaison with the market. Nathan has...
Expertise
Nathan Lim is the Chief Investment Officer at Lonsec Holdings. He is responsible for building and managing Lonsec’s suite of investment solutions, devising strategies for growth and acting as the liaison with the market. Nathan has...
Expertise
Comments
Comments
Sign In or Join Free to comment